Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2005 1
2006 1
2007 1
2008 2
2009 3
2010 3
2011 2
2012 5
2013 5
2014 4
2015 1
2016 1
2017 1
2018 2
2019 3
2020 1
2021 2
2022 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
The multi-disciplinary management of high-risk prostate cancer.
Picard JC, Golshayan AR, Marshall DT, Opfermann KJ, Keane TE. Picard JC, et al. Among authors: marshall dt. Urol Oncol. 2012 Jan-Feb;30(1):3-15. doi: 10.1016/j.urolonc.2009.09.002. Epub 2009 Nov 27. Urol Oncol. 2012. PMID: 19945310 Review.
Vitamin D3 supplementation, low-risk prostate cancer, and health disparities.
Hollis BW, Marshall DT, Savage SJ, Garrett-Mayer E, Kindy MS, Gattoni-Celli S. Hollis BW, et al. Among authors: marshall dt. J Steroid Biochem Mol Biol. 2013 Jul;136:233-7. doi: 10.1016/j.jsbmb.2012.11.012. Epub 2012 Dec 7. J Steroid Biochem Mol Biol. 2013. PMID: 23220550 Review.
Pediatric rhabdomyosarcoma of the head and neck.
Gillespie MB, Marshall DT, Day TA, Mitchell AO, White DR, Barredo JC. Gillespie MB, et al. Among authors: marshall dt. Curr Treat Options Oncol. 2006 Jan;7(1):13-22. doi: 10.1007/s11864-006-0028-3. Curr Treat Options Oncol. 2006. PMID: 16343365 Review.
Report from the SWOG Radiation Oncology Committee: Research Objectives Workshop 2017.
Okunieff P, Casey-Sawicki K, Lockney NA, Hoppe BS, Enderling H, Pinnix C, Welsh J, Krishnan S, Yothers G, Brown M, Knox S, Bristow R, Spellman P, Mitin T, Nabavizadeh N, Jaboin J, Manning HC, Feng F, Galbraith S, Solanki AA, Harkenrider MM, Tuli R, Decker RH, Finkelstein SE, Hsu CC, Ha CS, Jagsi R, Shumway D, Daly M, Wang TJC, Fitzgerald TJ, Laurie F, Marshall DT, Raben D, Constine L, Thomas CR Jr, Kachnic LA. Okunieff P, et al. Among authors: marshall dt. Clin Cancer Res. 2018 Aug 1;24(15):3500-3509. doi: 10.1158/1078-0432.CCR-17-3202. Epub 2018 Apr 16. Clin Cancer Res. 2018. PMID: 29661779
The Clinical Cell-Cycle Risk (CCR) Score Is Associated With Metastasis After Radiation Therapy and Provides Guidance on When to Forgo Combined Androgen Deprivation Therapy With Dose-Escalated Radiation.
Tward J, Lenz L, Flake DD II,, Rajamani S, Yonover P, Olsson C, Kapoor DA, Mantz C, Liauw SL, Antic T, Fabrizio M, Salzstein D, Shore N, Albertson D, Henderson J, Lee SP, Gay HA, Michalski J, Hung A, Raben D, Garraway I, Lewis MS, Nguyen PL, Marshall DT, Brawer MK, Stone S, Cohen T. Tward J, et al. Among authors: marshall dt. Int J Radiat Oncol Biol Phys. 2022 May 1;113(1):66-76. doi: 10.1016/j.ijrobp.2021.09.034. Epub 2021 Oct 3. Int J Radiat Oncol Biol Phys. 2022. PMID: 34610388 Free article.
Favorable Trisomies and ETV6-RUNX1 Predict Cure in Low-Risk B-Cell Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Trial AALL0331.
Mattano LA Jr, Devidas M, Maloney KW, Wang C, Friedmann AM, Buckley P, Borowitz MJ, Carroll AJ, Gastier-Foster JM, Heerema NA, Kadan-Lottick NS, Matloub YH, Marshall DT, Stork LC, Loh ML, Raetz EA, Wood BL, Hunger SP, Carroll WL, Winick NJ. Mattano LA Jr, et al. Among authors: marshall dt. J Clin Oncol. 2021 May 10;39(14):1540-1552. doi: 10.1200/JCO.20.02370. Epub 2021 Mar 19. J Clin Oncol. 2021. PMID: 33739852 Free PMC article.
33 results